MedTrace Logo

Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients

NCT06704113 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-11-25

No results posted yet for this study

Summary

Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.

Conditions

  • Dental Pain
  • Sensation Disorders

Interventions

DRUG

meloxicam 7,5mg

Comparison of analgesic efficacy of Meloxicam Vs Ibuprofen

Sponsors & Collaborators

  • Universidad Austral de Chile

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2025-01-15
Completion
2025-01-20
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06704113 on ClinicalTrials.gov